| Dr William John Peters, DPM | |
|
23100 Cherry Hill St, Dearborn, MI 48124-1493 | |
| (313) 278-5444 | |
| (313) 278-4800 |
| Full Name | Dr William John Peters |
|---|---|
| Gender | Male |
| Speciality | Podiatrist |
| Location | 23100 Cherry Hill St, Dearborn, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386607877 | NPI | - | NPPES |
| 4858210820 | Other | MI | BLUE CROSS BLUE SHIELD |
| 480H234160 | Other | MI | BCBSM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 5901000724 (Michigan) | Primary |
| 213E00000X | Podiatrist | P0790 (Florida) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr William John Peters, DPM 23100 Cherry Hill St, Suite 5, Dearborn, MI 48124-1493 Ph: (313) 278-5444 | Dr William John Peters, DPM 23100 Cherry Hill St, Dearborn, MI 48124-1493 Ph: (313) 278-5444 |
News Archive
Protagen AG, a specialist for in-vitro diagnostics and GMP-compliant protein analysis, announced today that it received a Notice of Allowance by the Japanese Patent Office stating a favourable decision for the patent application 2000-547262 developed at the Max-Planck Institute for Molecular Genetics in Berlin, Germany. This patent claims broadly a method for identifying and selecting clones relating to the basic UNIclone® technology and is already granted in Europe with the publication number EP1073770 B1.
The World Health Organisation (WHO) is quite rightly patting itself on the back because it has persuaded as many as 13 drug companies to abandon the marketing and promotion of monotherapy in the treatment of Malaria.
Hi-Tech Pharmacal Co., Inc., a specialty pharmaceuticals company, announced today that the US Food and Drug Administration, (FDA) granted tentative approval for the Company's Abbreviated New Drug Application, (ANDA) for brimonidine tartrate with timolol maleate ophthalmic solution, the generic for Allergan's Combigan® ophthalmic solution which had sales of $108 million for the 12 months ended December 2010 according to IMS sales data.
The major innovations in cancer diagnosis, therapy/palliative care and surgical intervention are too numerous to list here. But enormous strides have taken place in stem cell therapy, monoclonal antibody therapy and genetic screening.
› Verified 2 days ago
Dr. Daniel Salama, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2200 Monroe St Ste 1, Dearborn, MI 48124 Phone: 313-274-0990 Fax: 313-274-8120 | |
Premier Foot & Ankle Podiatrist Medicare: Medicare Enrolled Practice Location: 1213 Mason St, Dearborn, MI 48124 Phone: 313-561-2446 Fax: 313-561-7299 | |
Dr. Ali M. Safiedine, D.P.M. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 7243 Chase Rd, Dearborn, MI 48126 Phone: 313-582-6222 Fax: 313-582-0166 | |
Dr Ernest F Ajluni P C Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 4700 Greenfield Rd, Dearborn, MI 48126 Phone: 313-945-6100 Fax: 313-945-5260 | |
Dearborn Foot Specialists Podiatrist Medicare: Medicare Enrolled Practice Location: 2200 Monroe, Dearborn, MI 48124 Phone: 313-274-0990 Fax: 313-274-8120 | |
Dr. Fernando Luis Quirindongo-solano, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 7243 Chase Rd, Dearborn, MI 48126 Phone: 313-582-6222 Fax: 313-582-0166 | |
Daniel Salama Dpm Pc Podiatrist Medicare: Medicare Enrolled Practice Location: 2200 Monroe St Ste 1, Dearborn, MI 48124 Phone: 313-274-0990 Fax: 313-274-8120 |